- Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
- Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
- Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
- Senseonics Holdings, Inc. to Participate in Upcoming Conferences
- Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
- Eversense® CGM System Receives iCGM Designation by the US FDA
- Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
- Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
- Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
On Friday, Senseonics Holdings Inc (SENS:ASQ) closed at 0.4491, 17.01% above the 52 week low of 0.3838 set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4703 |
---|---|
High | 0.4742 |
Low | 0.4451 |
Bid | 0.4495 |
Offer | 0.46 |
Previous close | 0.4764 |
Average volume | 2.05m |
---|---|
Shares outstanding | 530.89m |
Free float | 504.62m |
P/E (TTM) | -- |
Market cap | 252.91m USD |
EPS (TTM) | -0.1354 USD |
Data delayed at least 15 minutes, as of May 24 2024.
More ▼